DG Peptide Protocols
Well StudiedWeight LossGrowth Hormone

GHRP-6

Growth Hormone Releasing Hexapeptide

Growth Hormone Releasing Peptide-6 | Hexapeptide GHS

Half-life
15-60 minutes
Chain length
6 amino acids
Reference frequency
2-3 times daily (morning, post-workout optional, before bed)

Research overview

DoseGear research brief

GHRP-6 is a synthetic growth hormone secretagogue that stimulates the pituitary gland to release growth hormone. It was one of the first GHRPs developed and works by binding to the ghrelin receptor (GHS-R1a). Unlike direct HGH injections, GHRP-6 enhances the body's natural GH production while keeping negative feedback mechanisms balanced. It is known for its potent appetite-stimulating effects.

Mechanism of action

GHRP-6 binds to the growth hormone secretagogue receptor (GHS-R1a), the same receptor activated by ghrelin. This initiates a signaling cascade in the hypothalamus and pituitary gland, triggering a rapid pulse of natural GH secretion. The released GH then signals the liver to secrete IGF-1, which promotes muscle growth and fat metabolism. GHRP-6 also stimulates ghrelin release, causing significant appetite increase.

Compound background

Development & research timeline

Study windows describe what researchers measured, not when an individual should expect a result.

Origin & development

Early synthetic growth-hormone-releasing peptide.

What it is researched for

Growth-hormone secretion, appetite, and endocrine research through GHS-R1a agonism.

Research observation window

No sourced clinical-benefit response window is reported.

Reference data

Lyophilized vial injectable protocols

Not personalized dosing instructions

Only injectable vial references are shown. Nasal, topical, and unsupported non-vial schedules are excluded.

Research contextAmountFrequencyRoute
GH optimization100 mcg2-3x dailySubQ
Enhanced results200-300 mcg2-3x dailySubQ
With GHRH (synergy)100 mcg each2-3x dailySubQ (combined)
Appetite/bulking100-200 mcgBefore mealsSubQ

Reference cycle

8-12 weeks

Reference storage

Lyophilized: 2-8°C refrigerated; Reconstituted: 2-8°C refrigerated, use within 28 days

Safety context

Reported side effects

  • Intense hunger/increased appetite (most notable side effect)
  • Water retention
  • Tingling or numbness in extremities
  • Tiredness or lethargy after injection
  • Mild headache

Contraindications & cautions

  • Active cancer or history of cancer
  • Pregnancy or breastfeeding
  • Pituitary disorders
  • Diabetes (use with caution)
  • WADA prohibited for competitive athletes

Scientific references

  1. 01

    Effects of GHRP-6 on Weight Gain and Fat Mass

    Scientific citationEffects of GHRP-6 on Weight Gain and Fat Mass. Endocrinology (2010).
  2. 02

    Synthetic Growth Hormone-Releasing Peptides: Cytoprotective Effects

    Scientific citationSynthetic Growth Hormone-Releasing Peptides: Cytoprotective Effects. Clinical Medicine Insights: Cardiology (2017).
  3. 03

    GHRP-6 Clinical Safety Trial

    Scientific citationGHRP-6 Clinical Safety Trial. Clinical Research (2015).

This DoseGear profile combines published scientific literature with lyophilized-vial protocol references. Citations are provided for independent review.

Related research profiles